| 121 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2026-04-17 | $3 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1973327FEC filing ↗ |
| 122 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | PRINCIPAL CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2026-05-17 | $3 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1996824FEC filing ↗ |
| 123 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-09-25 | $3 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 124 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | HARRIS VICTORY FUNDC00744946 | 2025-04-30 | $3 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903362FEC filing ↗ |
| 125 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | HARRIS VICTORY FUNDC00744946 | 2025-03-30 | $3 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1888100FEC filing ↗ |
| 126 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | HARRIS VICTORY FUNDC00744946 | 2025-05-30 | $3 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903362FEC filing ↗ |
| 127 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2026-03-17 | $3 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1966092FEC filing ↗ |
| 128 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2026-02-17 | $3 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1966092FEC filing ↗ |
| 129 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-12-08 | $3 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 130 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-11-24 | $3 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 131 | DEMELIA, HEATHERNorth Attleboro, MA · 02760 | Clinical Research Associate · GlaxoSmithKline | VINDMAN FOR CONGRESSC00856955 | 2026-09-01 | $4 | General 2026 (G2026) | Filing 2025808FEC filing ↗ |
| 132 | DEMELIA, HEATHERNorth Attleboro, MA · 02760 | Clinical Research Associate · GlaxoSmithKline | VINDMAN FOR CONGRESSC00856955 | 2026-08-01 | $4 | Primary 2026 (P2026) | Filing 2025808FEC filing ↗ |
| 133 | THORNTON, EILEENBuffalo Grove, IL · 60089 | Marketing & Sales Executive · Glaxosmithkline | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2026-08-19 | $4 | General 2026 (G2026) | Filing 2024431FEC filing ↗ |
| 134 | SAVAGE, MARYCHESTER SPRINGS, PA · 19425 | SCIENTIST · GSK | ACTBLUEC00401224 | 2026-08-28 | $4 | Primary (P) | CONTRIBUTION TO ACTBLUEFiling 2014422FEC filing ↗ |
| 135 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-09-27 | $4 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 136 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | VINDMAN FOR CONGRESSC00856955 | 2026-01-01 | $4 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1967050FEC filing ↗ |
| 137 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-12-17 | $4 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 138 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-12-16 | $4 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 139 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-07-24 | $4 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |
| 140 | LEWIS, ERICCHAPEL HILL, NC · 27517 | EXECUTIVE · GSK | ACTBLUEC00401224 | 2025-07-22 | $4 | Not reported | CONTRIBUTION TO ACTBLUEFiling 1953256 · amendedFEC filing ↗ |